Anterix Inc (ATEX) Key Metrics
ATEX valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $1.58B
- Enterprise value
- $1.53B
- P/E (TTM)
- 23.0
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- 224.1 10-yr median 131.6
- Price / book
- 5.8 10-yr median 3.3
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- 0.89
ATEX key metrics, FY2017–FY2026
Fiscal year ended March 31, 2026 · U.S. dollarsATEX valuation Price multiples at each fiscal year-end price.
ATEX returns How much profit the business earns on the capital it uses.
ATEX per-share figures Results divided by the shares outstanding at year-end.
ATEX financial health Debt, liquidity and how easily interest is covered.
ATEX efficiency & capital use Working capital cycle and where the cash goes.
ATEX valuation history
ATEX returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
ATEX debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
ATEX cash returned to shareholders
ATEX price vs earnings per share
ATEX key metrics
FY2017–FY2026| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $716.3M | $679.4M | $630.7M | $622.5M | $1.05B | $821.2M | $750.0M | $512.5M | $431.4M | $314.4M |
| Enterprise value | $622.2M | $637.4M | $578.3M | $584.0M | $950.5M | $710.7M | $621.3M | $435.8M | $333.1M | $190.8M |
| P/E ratio | 7.9 | — | — | — | — | — | — | — | — | — |
| Price / sales | 110.2 | 112.6 | 150.5 | 324.4 | 969.1 | 891.6 | 479.5 | 78.9 | 67.9 | 65.7 |
| Price / book | 2.7 | 4.3 | 3.9 | 3.5 | 5.6 | 3.9 | 3.1 | 2.8 | 2.1 | 1.4 |
| Price / free cash flow | 130.7 | — | 25.6 | — | — | — | — | — | — | — |
| Price / operating cash flow | 130.0 | — | 15.0 | — | 58.6 | — | — | — | — | — |
| EV / sales | 95.7 | 105.7 | 138.0 | 304.3 | 876.9 | 771.7 | 397.2 | 67.1 | 52.4 | 39.9 |
| EV / free cash flow | 113.5 | — | 23.5 | — | — | — | — | — | — | — |
| Earnings yield | 12.7% | −1.7% | −1.4% | −2.6% | −3.6% | −6.6% | −5.0% | −8.2% | −7.1% | −12.5% |
| Free cash flow yield | 0.8% | −7.0% | 3.9% | −8.7% | −0.9% | −2.9% | −4.7% | −4.8% | −5.8% | −9.2% |
| Shareholder yield (dividends + buybacks) | 0.1% | 1.2% | 3.9% | 1.3% | 1.4% | 0.0% | 0.1% | 0.0% | 0.2% | 0.0% |
| Share price at fiscal year-end | $38.19 | $36.60 | $33.61 | $33.04 | $57.90 | $47.16 | $45.67 | $35.16 | $29.85 | $21.85 |
| Per share | ||||||||||
| Revenue per share | $0.35 | $0.32 | $0.22 | $0.10 | $0.06 | $0.05 | $0.10 | $0.45 | $0.44 | $0.33 |
| Earnings per share | $4.83 | −$0.61 | −$0.49 | −$0.87 | −$2.07 | −$3.13 | −$2.29 | −$2.88 | −$2.12 | −$2.72 |
| Operating cash flow per share | $0.29 | −$1.58 | $2.24 | −$1.45 | $0.99 | −$0.57 | −$1.89 | −$1.58 | −$1.52 | −$1.85 |
| Free cash flow per share | $0.29 | −$2.56 | $1.31 | −$2.89 | −$0.52 | −$1.39 | −$2.15 | −$1.70 | −$1.72 | −$2.02 |
| Cash per share | $5.25 | $2.55 | $3.23 | $2.29 | $5.82 | $6.75 | $8.37 | $5.26 | $6.80 | $8.62 |
| Book value per share | $13.99 | $8.44 | $8.58 | $9.54 | $10.27 | $12.20 | $14.92 | $12.40 | $14.01 | $15.84 |
| Tangible book value per share | −$2.58 | −$3.90 | −$2.97 | −$1.18 | $1.94 | $5.19 | $8.13 | $5.01 | $6.62 | $8.55 |
| Capex per share | $0.00 | $0.98 | $0.92 | $1.44 | $1.51 | $0.81 | $0.27 | $0.11 | $0.20 | $0.17 |
| Debt per share | $0.24 | $0.29 | $0.44 | $0.25 | $0.31 | $0.41 | $0.53 | — | $0.01 | $0.03 |
| Shares outstanding | 18.8M | 18.6M | 18.8M | 18.8M | 18.1M | 17.4M | 16.4M | 14.6M | 14.5M | 14.4M |
| Change in shares outstanding | +1.0% | −1.1% | −0.4% | +3.8% | +4.2% | +6.0% | +12.7% | +0.9% | +0.4% | +1.7% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | 43.3% | −7.2% | −5.4% | −8.9% | −18.8% | −23.8% | −17.7% | −21.9% | −14.2% | −16.0% |
| Return on invested capital (ROIC) | −27.9% | −8.3% | −6.4% | −11.4% | −30.9% | −39.7% | −26.9% | −32.4% | −24.0% | −24.2% |
| Return on assets (ROA) | 22.7% | −3.5% | −3.0% | −5.8% | −13.9% | −20.9% | −16.2% | −20.1% | −13.1% | −15.1% |
| Return on tangible assets | 58.7% | −10.9% | −8.4% | −21.3% | −27.4% | −41.6% | −24.1% | −47.2% | −27.0% | −27.9% |
| Free cash flow margin | 84.3% | −786.7% | 588.3% | — | −876.2% | — | — | −380.9% | −391.3% | −606.6% |
| Income quality (OCF / net income) | 0.06 | — | — | — | — | — | — | — | — | — |
| Financial health | ||||||||||
| Total debt | $4.4M | $5.4M | $8.2M | $4.6M | $5.7M | $7.1M | $8.7M | — | $95,000 | $497,000 |
| Cash & short-term investments | $98.5M | $47.4M | $60.6M | $43.2M | $105.6M | $117.5M | $137.5M | $76.7M | $98.3M | $124.1M |
| Net debt | −$94.1M | −$42.0M | −$52.4M | −$38.5M | −$99.9M | −$110.5M | −$128.7M | −$76.7M | −$98.2M | −$123.6M |
| Debt / equity | 0.02 | 0.03 | 0.05 | 0.03 | 0.03 | 0.03 | 0.04 | — | 0.00 | 0.00 |
| Debt / assets | 0.01 | 0.02 | 0.03 | 0.02 | 0.02 | 0.03 | 0.03 | — | 0.00 | 0.00 |
| Current ratio | 3.33 | 2.23 | 4.07 | 1.86 | 12.01 | 14.05 | 16.11 | 8.86 | 19.18 | 26.63 |
| Quick ratio | 3.33 | 2.23 | 4.07 | 1.88 | 12.04 | 14.05 | 16.11 | 8.86 | 19.14 | 26.60 |
| Interest coverage | — | — | — | -0.2 | -658.0 | -7.2 | -23.7 | — | — | — |
| Working capital | $84.0M | $33.6M | $55.1M | $27.6M | $106.1M | $112.4M | $133.3M | $69.5M | $95.0M | $121.0M |
| Invested capital | $168.2M | $114.6M | $108.7M | $141.3M | $86.4M | $102.0M | $116.4M | $104.0M | $104.2M | $104.3M |
| Tangible asset value | −$48.4M | −$72.4M | −$55.7M | −$22.3M | $35.1M | $90.4M | $133.5M | $73.0M | $95.7M | $123.0M |
| Net current asset value | −$82.9M | −$115.7M | −$90.9M | −$39.3M | $14.1M | $80.5M | $119.8M | $62.4M | $82.4M | $108.1M |
| Graham number | $39.00 | — | — | — | — | — | — | — | — | — |
| Graham net-net per share | −$5.14 | −$6.55 | −$5.16 | −$2.41 | $0.22 | $4.42 | $7.01 | $4.19 | $5.62 | $7.44 |
| Capital allocation | ||||||||||
| Share buybacks (net) | $990,000 | $8.4M | $24.7M | $8.2M | $15.0M | $0 | $566,000 | $209,000 | $668,000 | $143,000 |
| Dividends + buybacks / free cash flow | 18.1% | — | 100.1% | — | — | — | — | — | — | — |
| Capex / revenue | 0.5% | 301.5% | 413.7% | 1,413.8% | 2,528.7% | 1,539.0% | 283.0% | 25.6% | 45.3% | 49.9% |
| Capex / operating cash flow | 0.6% | — | 41.3% | — | 153.0% | — | — | — | — | — |
| Capex / depreciation | 0.07 | 33.18 | 20.54 | 19.11 | 18.90 | 4.01 | 1.23 | 0.59 | 1.01 | 1.07 |
| Stock-based compensation / revenue | 176.8% | 224.4% | 370.0% | 931.4% | 1,256.9% | 1,729.1% | 372.5% | 158.5% | 88.2% | 99.1% |
| R&D / revenue | 72.3% | 95.1% | 135.9% | 231.3% | 331.5% | 471.6% | 188.8% | 35.6% | 37.0% | 48.4% |
| SG&A / revenue | 554.7% | 707.5% | 1,060.0% | 2,354.2% | 3,646.2% | 4,586.8% | 1,887.7% | 450.8% | 437.9% | 589.2% |
| Efficiency | ||||||||||
| Days sales outstanding | 580.3 | 561.5 | 973.5 | 1,338.3 | 40.7 | 12.9 | 58.9 | 38.7 | 45.1 | 44.4 |
| Days of inventory on hand | — | — | — | -23,944.0 | -17,374.0 | — | 0.0 | — | 7.0 | 5.7 |
| Days payables outstanding | 6,355.2 | — | 312.3 | 65,663.5 | 56,356.0 | 130.1 | 89.4 | 29.8 | 26.6 | 115.2 |
| Cash conversion cycle (days) | -5,775.0 | — | 661.2 | -88,269.2 | -73,689.3 | -117.2 | -30.5 | 13.1 | 25.5 | -65.1 |
| Receivables turnover | 0.63 | 0.65 | 0.37 | 0.27 | 8.96 | 28.34 | 6.19 | 9.43 | 8.09 | 8.22 |
| Payables turnover | 0.06 | 0.00 | 1.17 | 0.01 | 0.01 | 2.81 | 4.08 | 12.25 | 13.75 | 3.17 |
| Inventory turnover | — | — | — | — | — | — | 5,666,000.00 | — | 52.48 | 63.73 |
| Asset turnover | 0.02 | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 | 0.03 | 0.03 | 0.02 |
| Average receivables | $10.3M | $9.3M | $11.2M | $7.0M | $121,000 | $32,500 | $252,500 | $689,500 | $785,500 | $582,142 |
| Average payables | $8.1M | $913,000 | $725,500 | $899,500 | $772,000 | $572,500 | $694,000 | $611,000 | $574,500 | $2.2M |
| Average inventory | — | — | — | −$328,000 | −$238,000 | — | $0 | $86,500 | $150,500 | $110,602 |
| Intangibles / total assets | 66.8% | 68.7% | 66.7% | 72.5% | 52.5% | 48.3% | 41.7% | 54.8% | 48.5% | 42.7% |
Computed from ATEX's annual financial statements (latest annual report filed June 25, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
ATEX valuation and financial ratios
At the end of fiscal 2026 (March 31, 2026), Anterix traded at 7.9 times earnings. Based on the latest twelve months, the trailing P/E is 23.0. Anterix earned a return on equity of 43.3% and a return on invested capital of −27.9% in fiscal 2026. It ended the year with $4.4 million of debt and $98.5 million in cash and short-term investments, a net cash position of $94.1 million. It returned $1.0 million to shareholders: $0 in dividends and $1.0 million in share buybacks, 18% of free cash flow. The share count rose 30.3% from 14.4M to 18.8M over 9 years.
See the ATEX income statement, the ATEX chart for price history, or the ATEX stock overview for the latest quote and news.
ATEX key metrics FAQ
What is Anterix's P/E ratio?
Anterix's trailing P/E ratio is 23.0 based on the last twelve months of earnings (as of October 18, 2026). At the end of fiscal 2026 it was 7.9.
What is Anterix's return on equity?
Anterix's return on equity (ROE) was 43.3% in fiscal 2026: net income of $90.6 million on average shareholders' equity of $209.5 million.
What is Anterix's ROIC?
Anterix's return on invested capital was −27.9% in fiscal 2026, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Anterix have?
Anterix had total debt of $4.4 million at the end of fiscal 2026, a debt-to-equity ratio of 0.02 and more cash than debt.
Does Anterix buy back its shares?
Yes. Anterix spent $1.0 million on net share repurchases in fiscal 2026 Shares outstanding changed +1.0% over the year, to 18.8M..
What is Anterix's free cash flow yield?
Anterix generated $5.5 million of free cash flow in fiscal 2026, a free cash flow yield of 0.8% on its market value at year-end ($716.3 million).
What is Anterix's current ratio?
Anterix's current ratio was 3.33 at the end of fiscal 2026: current assets were 3.33 times current liabilities.